(4-Morpholinopyridin-2-yl)methanamine, 98%, 250mg

2-Cyclopentyl-2-phenylethan-1-ol, 98%, 10g

potassium trifluoro(oxolan-3-yl)boranuide, 97, 1g

(S)-2-((tert-Butoxycarbonyl)amino)-2-(2-methoxyphenyl)acetic acid, 95.0%, 100mg

(S)-1-(3-Fluorophenyl)ethylamine hydrochloride, 95.0%, 100mg

2-Phenylethyl Acetate>98.0%(GC)25g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 60, 500 ml, 90 mm, 1 Piece

2-(4-Butylbenzoyl)oxazole, 97.0%, 1g

tert-Butyl 11-aminoundecanoate, 98%, 250mg

(E)-2-Benzylidene-5-bromo-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one, 98.0%, 25mg

(S)-4-BENZYL-2-(PYRAZIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 250mg

N-(3-methoxyphenyl)-2,2-dimethylpropanamide, 97.0%, 25g

5-METHYL-7-METHOXYISOFLAVONE, 95%, 1g